Case Report: Extra skeletal Ewing's sarcoma of mediastinum: clinical experience and literature review [0.03%]
胸膜外尤文氏肉瘤的病例报告：临床经验与文献回顾
Xianwen Hu,Wei Zhao,Ronghua Yu et al.
Xianwen Hu et al.
Extraskeletal Ewing sarcoma (EES) is a malignant tumor that arises in soft tissues outside the skeleton. It commonly involves the paravertebral regions, the lower extremities, and the chest wall, with mediastinal involvement being less freq...
The dynamic systemic immuno-inflammatory index: a novel predictor of neoadjuvant chemotherapy response and outcome in high-risk pediatric neuroblastoma [0.03%]
动态全身免疫炎症指数：高危神经母细胞瘤新辅助化疗反应和疗效的新型预测指标
Chenglong Zhang,Xiaoyu Wang,Huizhong Niu et al.
Chenglong Zhang et al.
Background: High-risk neuroblastoma (HR-NB) has a high mortality rate and a long-term survival rate below 50%. Neoadjuvant chemotherapy (NAC) is essential for HR-NB treatment. However, real-time treatment response biomark...
Durvalumab consolidation therapy in patients with stage III small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysis [0.03%]
度伐利尤单抗作为小细胞肺癌化放疗后巩固治疗的成本效益分析：基于中国数据的研究
Hui Zhang,Yuhang Liu,Bikun Cai et al.
Hui Zhang et al.
Background: Limited-stage small-cell lung cancer (LS-SCLC) has suboptimal long-term survival despite standard chemoradiotherapy. Durvalumab, an anti-PD-L1 antibody, demonstrated survival benefits in the ADRIATIC Phase III...
Editorial: Exploring microbial interactions in pancreatic ductal adenocarcinoma microenvironment [0.03%]
述评：探讨微生物在胰腺导管腺癌微环境中的相互作用
Serena Veschi,Pierluigi Di Sebastiano,Gabriella Mincione
Serena Veschi
Case Report: Serplulimab-induced thyroid dysfunction in a patient with advanced small cell lung cancer [0.03%]
病例报告：塞普利单抗致小细胞肺癌患者甲状腺功能异常
Lu Lu,Lingxiang Liu,Wentong Fang et al.
Lu Lu et al.
Studies have shown that the application of immune checkpoint inhibitors (ICIs) in solid tumors can easily affect the endocrine system, causing disorders of thyroid function, which are usually reversible after treatment cessation in most pat...
Efficacy and safety of inotuzumab ozogamicin and its combination therapies in acute lymphoblastic leukemia: a systematic review and meta-analysis [0.03%]
伊尼妥单抗及其联合用药治疗急性淋巴细胞白血病疗效和安全性的系统评价和 Meta 分析
Changtao Lao,Jiange Wen,Yuezhen Wen
Changtao Lao
Background: Although treatment for acute lymphoblastic leukemia (ALL) has advanced considerably, adults with relapsed or refractory (R/R) disease continue to face a grave prognosis. Inotuzumab ozogamicin (InO), a CD22-dir...
Mesenchymal stem cells added to second-line therapy improve response and failure-free survival in steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A meta-analysis of randomized controlled trials [0.03%]
间充质干细胞联合二线疗法可改善单用二线药物治疗激素耐药性移植物抗宿主病后 allo-hsct 患者缓解率和无失败生存率：系统评价和 Meta 分析
Man Xiao,Yinghu Yan,Rui Zhang et al.
Man Xiao et al.
Background: Steroid-refractory acute graft-versus-host disease (aGVHD) remains a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT), with limited effective treatmen...
Overarching view of trends and disparities in malignant neoplasm of the ovary between 1999-2023: a comprehensive CDC WONDER database study [0.03%]
基于CDC WONDER数据库的1999-2023年卵巢恶性肿瘤流行趋势及差异的全面分析研究报告
Jaikin Patel,Daniel Murillo Armenta,Olivia Foley et al.
Jaikin Patel et al.
Background: Ovarian cancer contributes significantly to the morbidity and mortality rates for women worldwide. As observed with other types of cancer, health disparities disproportionately affect ovarian cancer incidence ...
Dual PI3K and HDAC inhibitor, CUDC-907, effectively inhibits endometrial cancer growth in vitro and in vivo [0.03%]
双PI3K和HDAC抑制剂CUDC-907有效抑制子宫内膜癌的体内和体外生长
Xudong Zhang,Vanessa Lazaro-Camp,Tianyue Li et al.
Xudong Zhang et al.
Purpose: Hyperactivation of the PI3K/AKT/mTOR pathway promotes tumor progression in many cancers. Among these, endometrial cancer (EC) exhibits the highest frequency of alterations in this pathway, making it an ideal mode...
A novel method for histopathological analysis of oral squamous cell carcinoma: a pilot study using three-dimensional imaging to enhance local control [0.03%]
一种新的口腔鳞状细胞癌组织病理分析方法：一项使用三维影像以增强局部控制力的试点研究
Adam Michcik,Rafał Pęksa,Łukasz Garbacewicz et al.
Adam Michcik et al.
One factor that enhances the survival of patients with oral squamous cell carcinoma (OSCC) is improved local control. Many prognostic factors (PF) influence a patient's prognosis, one of which is the correct histopathological excision margi...